Compare AdaptHealth Corp (AHCO) vs Sea Limited (SE) Price & Performance

AdaptHealth (AHCO) trades at $10.27, down 4.55% today, with neutral technical signals and mixed fundamental performance. The company reported Q1 2026 earnings miss with negative EPS of -$0.06 versus $0.0125 expected, continuing a pattern of recent quarterly misses. Despite revenue growth to $3.3B projected for 2026, net income remains negative with -2.43% margin. Analyst consensus remains bullish with 75% buy ratings and $14.80 price target, representing 44% upside potential from current levels.

The investment case balances strong analyst support and reasonable valuation (P/S 0.42, EV/EBITDA 7.17) against persistent profitability challenges. Recent refinancing improves financial flexibility, but execution on cost controls and margin improvement remains critical. The stock offers significant upside if management can translate revenue growth into sustainable profitability, though current negative earnings trend presents near-term headwinds.

Sea Limited (SE) trades at $104.23, up 0.9% on the day, with a bullish technical signal from moving averages but overbought RSI readings. The company shows strong revenue growth, with 2025 revenue reaching $22.94 billion and net income of $1.58 billion, though recent quarters have mixed earnings performance. Analyst consensus remains strongly positive with a $131 price target, supported by improving cash flow trends and expanding profitability.

The outlook for SE is favorable given robust growth in its digital ecosystem and positive analyst sentiment, but risks include competitive pressures in Southeast Asian markets and potential volatility from earnings misses. Investors should weigh the high P/E ratio of 41.34 against the company's accelerating top-line expansion and margin improvements.